Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126335821 | 12633582 | 1 | I | 20140912 | 20141009 | 20160809 | 20160809 | EXP | FR-PFIZER INC-2014278077 | PFIZER | 68.00 | YR | M | Y | 0.00000 | 20160809 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126335821 | 12633582 | 1 | PS | Fragmine | DALTEPARIN SODIUM | 1 | Subcutaneous | UNK | 20287 | SOLUTION FOR INJECTION | |||||||||
| 126335821 | 12633582 | 2 | SS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 2 G, DAILY | 62911 | 2 | G | ||||||||
| 126335821 | 12633582 | 3 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Ophthalmic | UNK | 0 | ||||||||||
| 126335821 | 12633582 | 4 | SS | TICARCILLIN | TICARCILLIN | 1 | Ophthalmic | UNK | 0 | ||||||||||
| 126335821 | 12633582 | 5 | SS | PERIKABIVEN | ALANINEARGININEASPARTIC ACIDCALCIUM CHLORIDEDEXTROSE MONOHYDRATEGLUTAMIC ACIDGLYCINEHISTIDINEISOLEUCINELEUCINELYSINE HYDROCHLORIDEMAGNESIUM SULFATE HEPTAHYDRATEMETHIONINEPHENYLALANINEPOTASSIUM CHLORIDEPROLINESERINESODIUM ACETATESODIUM GLYCEROPHOSPHATE ANHYDROUSSOYBEAN OILTHREONIN | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 126335821 | 12633582 | 6 | C | REYATAZ | ATAZANAVIR SULFATE | 1 | Oral | UNK | 0 | ||||||||||
| 126335821 | 12633582 | 7 | C | ZIAGEN | ABACAVIR SULFATE | 1 | Oral | UNK | 0 | ||||||||||
| 126335821 | 12633582 | 8 | C | EMTRIVA | EMTRICITABINE | 1 | Oral | UNK | 0 | ||||||||||
| 126335821 | 12633582 | 9 | C | KARDEGIC | ASPIRIN LYSINE | 1 | 0 | ||||||||||||
| 126335821 | 12633582 | 10 | C | EUPANTOL | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 126335821 | 12633582 | 11 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 126335821 | 12633582 | 12 | C | SEROPLEX | ESCITALOPRAM OXALATE | 1 | 0 | ||||||||||||
| 126335821 | 12633582 | 13 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 126335821 | 12633582 | 14 | C | FORLAX | POLYETHYLENE GLYCOL 4000 | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126335821 | 12633582 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126335821 | 12633582 | Stevens-Johnson syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126335821 | 12633582 | 1 | 20140906 | 0 | ||
| 126335821 | 12633582 | 2 | 20140910 | 20140915 | 0 | |
| 126335821 | 12633582 | 3 | 20140901 | 20140914 | 0 | |
| 126335821 | 12633582 | 4 | 20140901 | 20140914 | 0 | |
| 126335821 | 12633582 | 5 | 20140807 | 0 | ||
| 126335821 | 12633582 | 6 | 20140807 | 0 | ||
| 126335821 | 12633582 | 7 | 20140807 | 0 | ||
| 126335821 | 12633582 | 8 | 20140807 | 0 |